Differential regulation of lymphoproliferative responses to Trypanosoma cruzi antigen in patients with the cardiac or indeterminate form of Chagas disease

Clinical Immunology

Volumn 111, Issue 1, 2004, Pages 137-145

  De Barros Mazon, Sílvia ^a   Guariento, Maria E ^a   Da Silva, Cleide Aparecida ^a   Coffman, Robert L ^b,d   Abrahamsohn, Ises A ^c  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b MERCK RESEARCH LABORATORIES   (United States)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d Dynavax Technologies Corporation   (United States)

Author keywords

Chagas disease; Clinical forms; Cytokines; IL 10; Lymphocyte proliferation; PGE2; Suppression; Trypanosoma cruzi

Indexed keywords

GAMMA INTERFERON ANTIBODY; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; INDOMETACIN; INTERLEUKIN 10 ANTIBODY; INTERLEUKIN 13; INTERLEUKIN 4 ANTIBODY; MONOCLONAL ANTIBODY; N(G) METHYLARGININE; NEUTRALIZING ANTIBODY; NITRIC OXIDE; PARASITE ANTIGEN; PROSTAGLANDIN; PROSTAGLANDIN E2; SCAVENGER;

ADULT; AGED; ARTICLE; CELL PROLIFERATION; CHAGAS DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART DISEASE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE;

ADULT; AGED; ANIMALS; ANTIGENS, PROTOZOAN; CHAGAS DISEASE; CYTOKINES; DINOPROSTONE; FEMALE; HUMANS; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; TRYPANOSOMA CRUZI;

EID: 1842785723     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clim.2004.01.002     Document Type: Article

References (46)

1. Umezawa E.S., Stolf A.M., Corbett C.E., Shikanai-Yasuda M.A. Chagas' disease. Lancet. 357:2001;797-799.
2. Soares M.B., Santos R.R. Immunopathology of cardiomyopathy in the experimental Chagas' disease. Mem. Inst. Oswaldo Cruz. 94:1999;257-262.
3. Girones N., Fresno M. Etiology of Chagas' disease myocarditis: autoimmunity, parasite persistence, or both? Trends Parasitol. 19:2003;19-22.
4. Tarleton R.L. Chagas' disease: a role for autoimmunity? Trends Parasitol. 19:2003;447-451.
5. Kierszenbaum F., Sztein M. Trypanosoma cruzi. Kierszenbaum F. Parasitic Infections and the Immune System. 1994;53-75 Academic Press, San Diego.
6. Abrahamsohn I.A., Coffman R.L. Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection. J. Immunol. 155:1995;3955-3963.
7. Pinge Filho P., Tadokoro C.E., Abrahamsohn I.A. Prostaglandins mediate suppression of lymphocyte proliferation and cytokine synthesis in acute Trypanosoma cruzi infection. Cell. Immunol. 193:1999;90-98.
8. Soong L., Tarleton R.L. Trypanosoma cruzi infection suppresses nuclear factors that bind to specific sites on the interleukin-2 enhancer. Eur. J. Immunol. 24:1994;16-23.
9. Rottenberg M., Lindqvist C., Koman A., Segura E.L., Orn A. Modulation of both interleukin 2 receptor expression and interleukin 2 production during experimental murine Trypanosoma cruzi infection. Scand. J. Immunol. 30:1989;65-72.
10. Montufar O.M., Musatti C.C., Mendes E., Mendes N.F. Cellular immunity in chronic Chagas' disease. J. Clin. Microbiol. 5:1977;401-404.
11. Morato M.J., Brener Z., Cancado J.R., Nunes R.M., Chiari E., Gazzinelli G. Cellular immune responses of chagasic patients to antigens derived from different Trypanosoma cruzi strains and clones. Am. J. Trop. Med. Hyg. 35:1986;505-511.
12. De Titto E.H., Segura E.L., Braun M. Cellular immunity in Chagas' disease patients. Lymphoproliferative response to subcellular fractions of Trypanosoma cruzi. Immunol. Lett. 6:1983;161-167.
13. Gusmao R.D., Rassi A., Rezende J.M., Neva F.A. Specific and non-specific lymphocyte blastogenic responses in individuals infected with Trypanosoma cruzi. Am. J. Trop. Med. Hyg. 33:1984;827-834.
14. Mosca W., Plaja J., Hubsch R., Cedillos R. Longitudinal study of immune response in human Chagas' disease. J. Clin. Microbiol. 22:1985;438-441.
15. de Barros-Mazon S., Guariento M.E., Abrahamsohn I.A. IL-12 enhances proliferation of peripheral blood mononuclear cells from Chagas' disease patients to Trypanosoma cruzi antigen. Immunol. Lett. 57:1997;39-45.
16. Cetron M.S., Basilio F.P., Moraes A.P., Sousa A.Q., Paes J.N., Kahn S.J., Wener M.H., Van Voorhis W.C. Humoral and cellular immune response of adults from northeastern Brazil with chronic Trypanosoma cruzi infection: depressed cellular immune response to T. cruzi antigen among Chagas' disease patients with symptomatic vs indeterminate infection. Am. J. Trop. Med. Hyg. 49:1993;370-382.
17. M. Morato, Imunorregulação da resposta celular a extratos antigênicos do Trypanosoma cruzi em pacientes chagásicos das formas clinicas indeterminada e cardíaca. Thesis. Department of Immunology. Federal University of São Paulo, São Paulo, Brasil, 1994.
18. Doherty T.M. T-cell regulation of macrophage function. Curr. Opin. Immunol. 7:1995;400-404.
19. Schleifer K.W., Mansfield J.M. Suppressor macrophages in African trypanosomiasis inhibit T cell proliferative responses by nitric oxide and prostaglandins. J. Immunol. 151:1993;5492-5503.
20. Bogdan C., Nathan C. Modulation of macrophage function by transforming growth factor beta, interleukin-4, and interleukin-10. Ann. N. Y. Acad. Sci. 685:1993;713-739.
21. de Vries J.E. Molecular and biological characteristics of interleukin-13. Chem. Immunol. 63:1996;204-218.
22. Curotto de Lafaille M.A., Barbosa de Oliveira L.C., Lima G.C., Abrahamsohn I.A. Trypanosoma cruzi: maintenance of parasite-specific T cell responses in lymph nodes during the acute phase of the infection. Exp. Parasitol. 70:1990;164-174.
23. Abrams S., Roncarolo M.G., Yssel H., Andersson U., Gleich G.J., Silver J.E. Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol. Rev. 127:1992;5.
24. McKenzie A., Zurawski G. Measurement of IL-13. Coligan J., Kruisbeek A., Margulies D., Shevach E., Stroker W. Current Protocols in Immunology. 1995;1-5 Wiley, New York. Section 6.18.
25. Motran C., Gruppi A., Vullo C.M., Pistoresi-Palencia M.C., Serra H.M. Involvement of accessory cells in the Trypanosoma cruzi-induced inhibition of the polyclonal response of T lymphocytes, Paras. Immunology. 18:1996;43-48.
26. Van Overtvelt L., Vanderheyde N., Verhasselt V., Ismaili J., De Vos L., Goldman M., Willems F., Vray B. Trypanosoma cruzi infects human dendritic cells and prevents their maturation: inhibition of cytokines, HLA-DR, and costimulatory molecules. Infect. Immun. 67:1999;4033-4040.
27. de Waal Malefyt R., Yssel H., de Vries J.E. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J. Immunol. 150:1993;4754-4765.
28. Moore K.W., de Waal Malefyt R., Coffman R.L., O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19:2001;683-765.
29. Galvão da Silva A.P., Abrahamsohn I.A. Interleukin-12 stimulation of lymphoproliferative responses in Trypanosoma cruzi infection. Immunology. 104:2001;349-354.
30. Hunter C.A., Ellis Neyes L.A., Slifer T., Kanaly S., Grünig G., Fort M., Rennick D., Araujo F.G. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J. Immunol. 158:1997;3311-3316.
31. Abrahamsohn I.A., Coffman R.L. Trypanosoma cruzi: IL-10, TNF, IFN-gamma, and IL-12 regulate innate and acquired immunity to infection. Exp. Parasitol. 84:1996;231-244.
32. Pohl-Koppe A., Balashov K.E., Steere A.C., Logigian E.L., Hafler D.A. Identification of a T cell subset capable of both IFN-gamma and IL-10 secretion in patients with chronic Borrelia burgdorferi infection. J. Immunol. 160:1998;1804-1810.
33. Gerosa F., Nisii C., Righetti S., Micciolo R., Marchesini M., Cazzadori A., Trinchieri G. CD4(+) T cell clones producing both interferon-gamma and interleukin-10 predominate in bronchoalveolar lavages of active pulmonary tuberculosis patients. Clin. Immunol. 92:1999;224-334.
34. Gomes J.A., Bahia-Oliveira L.M., Rocha M.O., Martins-Filho O.A., Gazzinelli G., Correa-Oliveira R. Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response. Infect. Immun. 71:2003;1185-1193.
35. Abel L.C., Rizzo L.V., Ianni B., Albuquerque F., Bacal F., Carrara D., Bocchi E.A., Teixeira H.C., Mady C., Kalil J., Cunha-Neto E. Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection. J. Autoimmun. 17:2001;99-107.
36. Dutra W.O., Gollob K.J., Pinto Dias J.C., Gazzinelli G., Correa Oliveira R., Coffman R.L., Carvalho Parra J.F. Cytokine mRNA profile of peripheral blood mononuclear cells isolated from individuals with Trypanosoma cruzi chronic infection. Scand. J. Immunol. 45:1997;74-80.
37. Cuna W.R., Encina J.L., Cuna C.R. Interferon- or interleukin-10 production is induced by related Trypanosoma cruzi antigens. J. Parasitol. 86:2000;295-299.
38. Samudio M., Montenegro-James S., de Cabral M., Martinez J., Rojas de Arias A., Woroniecky O., James M.A. Differential expression of systemic cytokine profiles in Chagas' disease is associated with endemicity of Trypanosoma cruzi infections. Acta Trop. 69:1998;89-97.
39. Tilley S.L., Coffman T.M., Koller B.H. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J. Clin. Invest. 108:2001;15-23.
40. Betz M., Fox B.S. Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J. Immunol. 146:1991;108-113.
41. Rincon M., Tugores A., Lopez-Rivas A., Silva A., Alonso M., De Landazuri M.O., Lopez-Botet M. Prostaglandin E2 and the increase of intracellular cAMP inhibit the expression of interleukin 2 receptors in human T cells. Eur. J. Immunol. 18:1988;1791-1796.
42. Daugschies A., Joachim A. Eicosanoids in parasites and parasitic infections. Adv. Parasitol. 46:2000;181-240.
43. Reis M.M., Higuchi M de L., Benvenuti L.A., Aiello V.D., Gutierrez P.S., Bellotti G., Pileggi F. An in situ quantitative immunohistochemical study of cytokines and IL-2R+ in chronic human chagasic myocarditis: correlation with the presence of myocardial Trypanosoma cruzi antigens. Clin. Immunol. Immunopathol. 83:1997;165-172.
44. van der Pouw Kraan T.C., Boeije L.C., Smeenk R.J., Wijdenes J., Aarden L.A. Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J. Exp. Med. 181:1995;775-779.
45. Demeure C.E., Yang L.P., Desjardins C., Raynauld P., Delespesse G. Prostaglandin E2 primes naive T cells for the production of anti-inflammatory cytokines. Eur. J. Immunol. 27:1997;3526-3531.
46. Galvão da Silva A.P., Jacysyn J., Abrahamsohn I.A. Resistant mice lacking IL-12 become susceptible to Trypanosoma cruzi infection but fail to mount a TH2 response. Immunology. 108:2003;230-237.